{
  "type": "hyp",
  "text": "The p65 protein was coimmunoprecipitated with IkappaB-alpha (1:200) and was halved in Tat-positive cells where Tat coimmunoprecipitated with IkappaB-alpha (Figure 4D lanes 1 and 4) indicating that Tat competed the IkappaB-alpha binding to p65 in a dose-dependent manner (Figure 4E lanes 4 and 4).\n",
  "self": {
    "NER": {
      "answers": [
        "1:200",
        "Tat-positive",
        "4D",
        "1",
        "4",
        "Tat",
        "4E",
        "4",
        "4"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was the ratio of p65 protein to IkappaB-alpha?",
          "What type of cells showed a halved p65 protein?",
          "What is the lanes 1 and 4 of the figure?",
          "What is the dose-dependent manner in which Tat competes with IkappaB-",
          "What is the lanes 1 and 4 of the Figure 4D?",
          "What protein coimmunoprecipitated with IkappaB-al",
          "What is the lanes 4 and 4 of the Figure 4D?",
          "What is the lanes 1 and 4 of the Figure 4D?",
          "What is the lanes 1 and 4 of the Figure 4D?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "The p65 protein",
        "IkappaB-alpha",
        "Tat-positive cells",
        "Tat",
        "IkappaB-alpha",
        "Figure 4D",
        "Tat",
        "a dose-dependent manner",
        "Figure 4E"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was coimmunoprecipitated with IkappaB-al",
          "What protein was p65 coimmunoprecipitated with?",
          "What type of cells showed a halved p65 protein?",
          "What protein coimmunoprecipitated with IkappaB-al",
          "What protein was p65 coimmunoprecipitated with?",
          "What is the lanes 1 and 4 of the figure showing that Tat competed with Ik",
          "What protein coimmunoprecipitated with IkappaB-al",
          "How did Tat compete with IkappaB-alpha binding to p65?",
          "What is the lanes 4 and 4 of the figure?"
        ]
      }
    }
  },
  "asked": {
    "What is the main component of the NF-kappaB activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0016040205955505371,
        "ground_truth": {
          "Tat": {
            "bertscore": 0.6546971797943115,
            "f1": 0
          },
          "newly synthesized IkappaB-alpha": {
            "bertscore": 0.6264451742172241,
            "f1": 0
          }
        }
      }
    },
    "What is the main factor that causes Tat to be able to sustain NF-kapp": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.04049801826477051,
        "ground_truth": {
          "presence": {
            "bertscore": 0.7271952033042908,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the protein that is used to synthesize Tat?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.14051079750061035,
        "ground_truth": {
          "IkappaB-alpha": {
            "bertscore": 0.6390498876571655,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the protein that is coimmunoprecipitated with": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "p65",
        "answerability": 0.9008709788322449,
        "ground_truth": {
          "p65": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    }
  }
}